MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2032

Conditions
Valvular Heart Disease
Trial Locations (2)

Unknown

Chu Lille- Hopital Cardiologique, Lille

Chu Lariboisiere (Aphp), Paris

All Listed Sponsors
lead

French Cardiology Society

OTHER

NCT07176507 - MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease | Biotech Hunter | Biotech Hunter